{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:22:43Z","timestamp":1779294163223,"version":"3.51.4"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Tregitopes (T regulatory epitopes) are IgG-derived peptides with high affinity to major histocompatibility complex class II (MHCII), that are known to promote tolerance by activating T regulatory cell (Treg) activity. Here we characterized the effect of IgG Tregitopes in a well-established murine model of allergic asthma, demonstrating <jats:italic>in vivo<\/jats:italic> antigen-specific tolerance <jats:italic>via<\/jats:italic> adoptive transfer of Tregitope-and-allergen-activated Tregs. Asthma is a heterogeneous chronic inflammatory condition affecting the airways and impacting over 300 million individuals worldwide. Treatment is suppressive, and no current therapy addresses immune regulation in severely affected asthmatics. Although high dose intra-venous immunoglobulin (IVIg) is not commonly used in the asthma clinic setting, it has been shown to improve severe asthma in children and in adults. In our laboratory, we previously demonstrated that IVIg abrogates airway hyperresponsiveness (AHR) in a murine model of asthma and induces suppressive antigen-specific T-regulatory cells. We hypothesized that IgG-derived Tregitopes would modulate allergic airway disease by inducing highly suppressive antigen-specific Tregs capable of diminishing T effector cell responses and establishing antigen-specific tolerance.\u00a0Using ovalbumin (OVA-) and ragweed-driven murine models of allergic airway disease, we characterized the immunoregulatory properties of Tregitopes and performed Treg adoptive transfer to OVA- and ragweed-allergic mice to test for allergen specificity. Treatment with Tregitopes attenuated allergen-induced airway hyperresponsiveness and lung inflammation. We demonstrated that Tregitopes induce highly suppressive allergen-specific Tregs. The tolerogenic action of IgG Tregitopes in our model is very similar to that of IVIg, so we foresee that IgG Tregitopes could potentially replace steroid-based treatment and can offer a synthetic alternative to IVIg in a range of inflammatory and allergic conditions. <\/jats:p>","DOI":"10.3389\/fimmu.2021.634509","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T04:19:06Z","timestamp":1618805946000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Tregitopes Improve Asthma by Promoting Highly Suppressive and Antigen-Specific Tregs"],"prefix":"10.3389","volume":"12","author":[{"given":"Marieme","family":"Dembele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir H.","family":"Massoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M. Shahjahan","family":"Miah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Lelias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne S.","family":"De Groot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce D.","family":"Mazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00246","article-title":"Epidemiology of Asthma in Children and Adults","volume":"7","author":"Dharmage","year":"2019","journal-title":"Front Pediatr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2019.05.031","article-title":"Phenotypes and endotypes of adult asthma: Moving toward precision medicine","volume":"144","author":"Kaur","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jaci.2013.09.029","article-title":"Dendritic cell immunoreceptor: A novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells","volume":"133","author":"Massoud","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.7748\/ns2011.10.26.5.48.c8744","article-title":"Asthma: pathophysiology, diagnosis and management","volume":"26","author":"Kaufman","year":"2011","journal-title":"Nurs Stand"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502361","article-title":"Peripherally Generated Foxp3 + Regulatory T Cells Mediate the Immunomodulatory Effects of IVIg in Allergic Airways Disease","volume":"198","author":"Massoud","year":"2017","journal-title":"J Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/493138","article-title":"Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG","volume":"2013","author":"De Groot","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-138073","article-title":"Activation of natural regulatory T cells by IgG Fc\u2013derived peptide \u201cTregitopes.\u201d","volume":"112","author":"De Groot","year":"2008","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"16103","DOI":"10.1038\/s41598-019-52331-1","article-title":"Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction","volume":"9","author":"De Groot","year":"2019","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"15480","DOI":"10.1038\/s41598-018-33680-9","article-title":"Tregitope-linked Refined Allergen Vaccines for Immunotherapy in Cockroach Allergy","volume":"8","author":"Prangtaworn","year":"2018","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.3748\/wjg.v18.i32.4288","article-title":"Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis","volume":"18","author":"van der Marel","year":"2012","journal-title":"World J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"10531","DOI":"10.1038\/s41598-020-66957-z","article-title":"Tregitopes regulate the tolerogenic immune response and decrease the foetal death rate in abortion-prone mouse matings","volume":"10","author":"Kedzierska","year":"2020","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.08.017","article-title":"Tregitope update: Mechanism of action parallels IVIg","volume":"12","author":"Cousens","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4049\/jimmunol.1600831","article-title":"Semaphorin 4C Protects against Allergic Inflammation: Requirement of Regulatory CD138 + Plasma Cells","volume":"198","author":"Xue","year":"2017","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2010.03663.x","article-title":"Intravenous immunoglobulin attenuates airway hyperresponsiveness in a murine model of allergic asthma","volume":"41","author":"Kaufman","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.jaci.2012.02.050","article-title":"Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3\u2013positive regulatory T cells","volume":"129","author":"Massoud","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4837","article-title":"IL-17A-producing T cells are associated with the progression of lung adenocarcinoma","volume":"36","author":"Bao","year":"2016","journal-title":"Oncol Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/621693","article-title":"Application of IgG-Derived Natural Treg Epitopes (IgG Tregitopes) to Antigen-Specific Tolerance Induction in a Murine Model of Type 1 Diabetes","volume":"2013","author":"Cousens","year":"2013","journal-title":"J Diabetes Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0034547","article-title":"Phenotypic and functional properties of Helios + regulatory T cells","volume":"7","author":"Zabransky","year":"2012","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bjorl.2019.12.001","article-title":"Difference between CD25+Tregs and Helios+Tregs in a murine model of allergic rhinitis","author":"Wang","year":"2020","journal-title":"Braz J Otorhinolaryngol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/art.39091","article-title":"Helios enhances treg cell function in cooperation with FoxP3","volume":"67","author":"Takatori","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102964","article-title":"Expression of Helios in Peripherally Induced Foxp3 + Regulatory T Cells","volume":"188","author":"Gottschalk","year":"2012","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2014.10.012","article-title":"Tregitope: Immunomodulation Powerhouse","volume":"75","author":"Cousens","year":"2014","journal-title":"Hum Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2013.09.006","article-title":"T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation","volume":"149","author":"Jawa","year":"2013","journal-title":"Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4161\/hv.24615","article-title":"The two-faced T cell epitope: examining the host-microbe interface with JanusMatrix","volume":"9","author":"Moise","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"B28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1182\/blood.V114.22.377.377","article-title":"Suppression of CTL Responses against AAV-Capsid Epitopes by Peptide-Induced Regulatory T Cells","volume":"114","author":"Hui","year":"2009","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.166","article-title":"Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes","volume":"21","author":"Hui","year":"2013","journal-title":"Mol Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.08.008","article-title":"Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin","volume":"38","author":"Maddur","year":"2017","journal-title":"Trends Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(91)90420-S","article-title":"An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma","volume":"87","author":"Mazer","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/cei.1996.104.s1.61","article-title":"Intravenous immune globulin: an alternative therapy in steroid-dependent allergic diseases","volume":"104","author":"Gelfand","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1991.tb05794.x","article-title":"Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases","volume":"86","author":"Kaveri","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181dd6bf1","article-title":"Intravenous Immunoglobulins Promote Skin Allograft Acceptance by Triggering Functional Activation of CD4+Foxp3+ T cells","volume":"89","author":"Tha-In","year":"2010","journal-title":"Transplantation"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.10.5019","article-title":"Epitope-specific tolerance induction with an engineered immunoglobulin","volume":"93","author":"Zambidis","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse Effects of Immunoglobulin Therapy","volume":"9","author":"Guo","year":"2018","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.634509\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T04:19:08Z","timestamp":1618805948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.634509\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2021.634509"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.634509","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]},"article-number":"634509"}}